|
|

楼主 |
发表于 2025-5-3 20:37:44
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑
$ r, r0 N* M3 }! x. @6 A2 U! d' S% U( Y+ p! v! d& @
今年ASCO大会,肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU,腹部肿瘤和生物治疗科今年哑火了9 e5 M3 z& ?+ A$ L
# Z; }8 z' g; A' Y6 J8 Q
头颈肿瘤BU入选ASCO 2025的研究
; Z% x {- g3 c4 ~$ k( BHot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.% W- i x6 j' B
肿瘤内科-头颈肿瘤科姜愚团队 p/ b$ N d; R# i: T8 k. `# J! i9 _' D
d, m9 b' @8 S" M: ^- ~( V0 t7 W$ CNeoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial.
4 H; n& J& n7 X# i$ z0 l# z5 a肿瘤内科-头颈肿瘤科刘磊团队
+ B+ M+ B4 v7 J, n7 Q9 d
% w' w$ |+ o- iA phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy.4 E* W( V; a, i S! m
肿瘤内科-头颈肿瘤科刘磊团队
6 X$ G3 }& b# ?6 ], ]' m: L N ]$ _( F
A phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy.
9 u" n0 b, f; L+ L. O肿瘤内科-头颈肿瘤科刘磊团队7 x: c* ]1 o5 e5 {+ E: O
5 @, |: A( O+ P; u
ribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.
/ _$ Q) }6 ~# j8 W: z9 N肿瘤内科-头颈肿瘤科姜愚团队* _( \2 |+ U: Y, [' n
|
|